BeOne Medicines
ONC
#647
Rank
C$50.04 B
Marketcap
C$452.25
Share price
1.11%
Change (1 day)
53.97%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2025 (TTM): C$0.82

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is C$0.90. In 2024 the company made an earnings per share (EPS) of C-$8.64.

EPS history for BeOne Medicines from 2015 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$0.82-109.43%
2024C-$8.64
2022C-$27.0128.21%
2021C-$21.07-19.96%
2020C-$26.3220.81%
2019C-$21.7931.52%
2018C-$16.57417.57%
2017C-$3.20-37.16%
2016C-$5.09158.95%
2015C-$1.97

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
C-$1.32-246.15%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
C-$0.33-136.92%๐Ÿ‡บ๐Ÿ‡ธ USA